Showing results (691-700 of 787) with videos related to
Sort By:
Pageof 79
Diabetes Care|October 24, 2008
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot studyDavid Z I Cherney, Ana Konvalinka, Bernard Zinman, et al.BMC Medicine|March 24, 2017
Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertilityDimitrios Korbakis, Christina Schiza, Davor Brinc, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patientsC V Obiezu, A Scorilas, D Katsaros, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancerGeorge M Yousef, Nicole M A White, Lisa Kurlender, et al.The Journal of Biological Chemistry|November 18, 2006
Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14Carla A Borgoño, Iacovos P Michael, Julie L V Shaw, et al.Biological Chemistry|July 17, 2008
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegenerationIsobel A Scarisbrick, Rachel Linbo, Alexander G Vandell, et al.Journal of Proteome Research|May 1, 2018
Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical ApplicationsIlijana Begcevic, Davor Brinc, Lora Dukic, et al.Biological Chemistry|August 3, 2016
Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancerNancy Ahmed, Julia Dorn, Rudolf Napieralski, et al.Clinical Chemistry|July 27, 2002
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancerGeorge M Yousef, Andreas Scorilas, Lianna G Kyriakopoulou, et al.BMC Medicine|July 30, 2016
Major milestones in translational oncologyTommaso A Dragani, Antoni Castells, Vathany Kulasingam, et al.Pageof 79